Feasibility Study of Multiorgan Dosiomics for Evaluating Radiation-Induced Xerostomia and Dysphagia in Head and Neck Cancer Radiotherapy

多器官剂量学在评估头颈癌放疗引起的放射性口干和吞咽困难中的可行性研究

阅读:2

Abstract

Background/Objectives: The severity of radiation-induced toxicity in head and neck cancer (HNC) radiotherapy should be predicted for the prognosis of the patient's quality of life. Multiple organs at risk (OARs) are susceptible to toxicity in the head and neck. Hence, we aimed to investigate the feasibility of evaluating radiation-induced xerostomia and dysphagia based on multi-OAR dosiomics in HNC radiotherapy. Methods: We used radiotherapy treatment planning and toxicity data collected from 44 patients with HNC. High- and low-toxicity grades were classified using dosiomic models derived from multiple OARs. Dosiomic features were computed from the planned dose distribution per OAR. A prediction model was derived using selected dosiomic features and toxicity grades based on extreme gradient boosting for every OAR and all OARs. The model performance was evaluated in terms of the area under the curve (AUC) from leave-one-out cross-validation. Models based on dose volume histogram features and combining these with dosiomic features were derived to compare the prediction performance per OAR. Performance comparisons across OARs were also conducted. Results: The prediction models with the highest AUCs for xerostomia and dysphagia were the dosiomic model using all OARs, with an AUC of 0.843 (95% confidence interval-CI, 0.725-0.961), and that using the middle pharyngeal constrictor muscle, with an AUC of 0.878 (95% CI, 0.772-0.984). Conclusions: The evaluation results demonstrated the feasibility and potential of predicting radiation-induced toxicities based on multi-OAR dosiomics in HNC radiotherapy. Further investigations are required to determine the generalizability of our findings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。